Pershing Square Capital Management, L.P.
Bill Ackman
Portfolio value
$13.71BQ1 2026
Quarterly filings
| Year | Quarter | Portfolio value | Positions | Largest holding |
|---|---|---|---|---|
| 2026 | Q1 2026 filed May 15, 2026 | $13.71B | 11 | BN 17.6% |
| 2025 | Q4 2025 filed Feb 17, 2026 | $15.53B | 11 | BN 18.1% |
| Q3 2025 filed Nov 14, 2025 | $14.64B | 11 | UBER 20.3% | |
| Q2 2025 filed Aug 14, 2025 | $13.73B | 11 | UBER 20.6% | |
| Q1 2025 filed May 15, 2025 | $11.93B | 11 | UBER 18.5% | |
| 2024 | Q4 2024 filed Apr 16, 2025 | $12.66B | 11 | BN 15.8% |
| Q3 2024 filed Nov 14, 2024 | $12.92B | 11 | BN 13.5% | |
| Q2 2024 filed Aug 14, 2024 | $10.41B | 9 | HLT 18.8% | |
| Q1 2024 filed May 15, 2024 | $10.76B | 7 | CMG 20.1% | |
| 2023 | Q4 2023 filed Feb 14, 2024 | $10.40B | 8 | CMG 18.1% |
| Q3 2023 filed Nov 14, 2023 | $10.49B | 8 | CMG 16.6% | |
| Q2 2023 filed Aug 14, 2023 | $10.82B | 8 | CMG 18.9% | |
| Q1 2023 filed May 15, 2023 | $10.22B | 8 | LOW 19.6% | |
| 2022 | Q4 2022 filed Feb 10, 2023 | $8.78B | 6 | LOW 23.5% |
| Q3 2022 filed Nov 14, 2022 | $7.88B | 6 | LOW 24.7% | |
| Q2 2022 filed Aug 15, 2022 | $7.46B | 7 | LOW 23.9% | |
| Q1 2022 filed May 16, 2022 | $10.39B | 8 | LOW 19.9% | |
| 2021 | Q4 2021 filed Mar 4, 2022 | $10.78B | 7 | LOW 24.5% |
| Q3 2021 filed Nov 15, 2021 | $9.46B | 6 | LOW 21.9% | |
| Q2 2021 filed Aug 16, 2021 | $10.71B | 7 | LOW 18.4% | |
| Q1 2021 filed May 17, 2021 | $10.46B | 7 | LOW 21.7% | |
| 2020 | Q4 2020 filed Feb 16, 2021 | $10.00B | 7 | LOW 19.9% |
| Q3 2020 filed Oct 23, 2020 | $8.82B | 7 | LOW 23.3% | |
| Q2 2020 filed Aug 14, 2020 | $7.75B | 7 | LOW 22.1% | |
| Q1 2020 filed May 15, 2020 | $6.57B | 10 | LOW 16.0% | |
| 2019 | Q4 2019 filed Feb 14, 2020 | $6.55B | 8 | CMG 22.0% |
| Q3 2019 filed Dec 9, 2019 | $6.49B | 8 | CMG 22.3% | |
| Q2 2019 filed Aug 14, 2019 | $6.71B | 8 | CMG 19.5% | |
| Q1 2019 filed May 15, 2019 | $6.72B | 8 | CMG 19.7% | |
| 2018 | Q4 2018 filed Feb 14, 2019 | $5.96B | 9 | QSR 17.3% |
| Q3 2018 filed Nov 14, 2018 | $5.21B | 7 | QSR 23.7% | |
| Q2 2018 filed Aug 14, 2018 | $5.80B | 8 | QSR 21.7% | |
| Q1 2018 filed May 15, 2018 | $4.83B | 7 | QSR 28.6% | |
| 2017 | Q4 2017 filed Feb 14, 2018 | $5.87B | 7 | QSR 27.7% |
| Q3 2017 filed Nov 14, 2017 | $5.11B | 6 | QSR 33.1% | |
| Q2 2017 filed Aug 14, 2017 | $6.01B | 7 | QSR 40.7% | |
| Q1 2017 filed May 15, 2017 | $5.96B | 7 | QSR 36.6% | |
| 2016 | Q4 2016 filed Feb 14, 2017 | $5.91B | 8 | QSR 31.6% |
| Q3 2016 filed Nov 14, 2016 | $5.41B | 9 | QSR 32.2% | |
| Q2 2016 filed Aug 15, 2016 | $7.51B | 9 | QSR 21.7% | |
| Q1 2016 filed May 16, 2016 | $8.85B | 9 | ZTS 20.9% | |
| 2015 | Q4 2015 filed Feb 16, 2016 | $12.46B | 8 | APD 21.5% |
| Q3 2015 filed Nov 16, 2015 | $13.95B | 8 | VALEANT PHARMACEUTICALS INTL 24.9% | |
| Q2 2015 filed Aug 14, 2015 | $14.45B | 7 | VALEANT PHARMACEUTICALS INTL 29.9% | |
| Q1 2015 filed May 15, 2015 | $14.97B | 8 | VALEANT PHARMACEUTICALS INTL 25.8% | |
| 2014 | Q4 2014 filed Feb 17, 2015 | $16.04B | 7 | ALLERGAN INC 35.3% |
| Q3 2014 filed Nov 14, 2014 | $13.43B | 7 | ALLERGAN INC 38.3% | |
| Q2 2014 filed Aug 14, 2014 | $12.60B | 6 | ALLERGAN INC 38.8% | |
| Q1 2014 filed May 15, 2014 | $8.38B | 9 | CANADIAN PAC RY LTD 30.8% | |
| 2013 | Q4 2013 filed Feb 14, 2014 | $8.23B | 7 | CANADIAN PAC RY LTD 31.5% |
| Q3 2013 filed Nov 14, 2013 | $10.28B | 8 | CANADIAN PAC RY LTD 27.7% | |
| Q2 2013 filed Aug 14, 2013 | $10.95B | 10 | CANADIAN PAC RY LTD 26.8% |
Holdings reflect long positions disclosed in 13F filings only and exclude short positions, cash, and other non-13F assets. Holdings data sourced from SEC EDGAR. Not investment advice. Full disclaimer.